Maze Therapeutics President, R&D and CMO Harold Bernstein disposes of 9,705 common shares for $254,543 - MAZE News | RalliesMaze Therapeutics President, R&D and CMO Harold Bernstein disposes of 9,705 common shares for $254,543
M
MAZE• Harold Bernstein sells Maze Therapeutics shares
- Harold Bernstein, President, R&D & CMO, sold 9,705 shares of Maze Therapeutics common stock on Sept. 4, 2026.
- Sale price was USD 26.22 per share on a weighted-average basis.
- Post-transaction holding reported at 0 shares.
•
